Arthralgia (Joint Pain) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Arthralgia Clinical Trial Report Overview
A total of 713 Arthralgia clinical trials were conducted as of March 2024. The Arthralgia clinical trial report provides a comprehensive understanding of the Arthralgia clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials.
Key Regions | · North America
· Europe · Asia-Pacific · Middle East and Africa · South and Central America |
Key Countries | · The US
· Australia · China · Iran · The UK |
Key Sponsor Types | · Company
· Institution · Government |
Leading Sponsors | · Novartis AG
· Johnson & Johnson · Reckitt Benckiser Group Plc · Grunenthal GmbH · IBSA Institut Biochimique SA |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Arthralgia Clinical Trials Segmentation by Regions and Countries
As of March 2024, APAC led the Arthralgia clinical trials landscape with more than 45% of the clinical trials conducted there
The key regions considered for Arthralgia clinical trials analysis are North America, Europe, Asia-Pacific, the Middle East and Africa, and South and Central America.
In the country-wise analysis, China had the highest number of Arthralgia clinical trials as of March 2024. The US had the highest average patient enrollment in Arthralgia clinical trials during the same time.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Japan held the highest proportion of Arthralgia to Central Nervous System clinical trials as of March 2024.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia held the highest proportion of Arthralgia to Central Nervous System clinical trials as of March 2024.
Arthralgia Clinical Trials Analysis by Regions, 2024 (%)
Buy the Full Report for More Regional Insights into the Arthralgia Clinical Trials
Download a Free Sample Report
Arthralgia Clinical Trials Segmentation by Sponsor Types
The key sponsor types for Arthralgia clinical trials are company, institution, and the government. As of March 2024, the company sponsor type conducted more than 50% of Arthralgia clinical trials.
Arthralgia Clinical Trials Analysis by Sponsor Types, 2024 (%)
Buy the Full Report for More Sponsor Type Insights into the Arthralgia Clinical Trials
Arthralgia Clinical Trials - Competitive Landscape
In 2024, Novartis AG conducted the highest number of Arthralgia clinical trials
A few of the leading sponsors for Arthralgia clinical trials are:
- Novartis AG
- Johnson & Johnson
- Reckitt Benckiser Group Plc
- Grunenthal GmbH
- IBSA Institut Biochimique SA
Arthralgia Clinical Trials Analysis by Sponsors, 2024 (%)
Buy the Full Report to Know More about the Leading Sponsors of Arthralgia Clinical Trials
Segments Covered in the Report
Arthralgia Clinical Trials Regional Outlook (2024)
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South and Central America
Arthralgia Clinical Trials Country Outlook (2024)
- The US
- Australia
- China
- Iran
- The UK
Arthralgia Clinical Trials Sponsor Type Outlook (2024)
- Company
- Institution
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Reasons to Buy
- The report provides a snapshot of the global clinical trials landscape.
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status.
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) of the company.
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for accomplishment.
- The report provides enrollment trends for the past five years.
- The report provides the latest news for the past three months.
Johnson & Johnson
Reckitt Benckiser Group Plc
Grunenthal GmbH
IBSA Institut Biochimique SA
GSK plc
Sandoz Group AG
Atoll
ESM Technologies LLC
Pfizer Inc
Table of Contents
Table
Figures
Frequently asked questions
-
Which region accounted for the highest number of Arthralgia clinical trials in March 2024?
APAC accounted for the highest number of Arthralgia clinical trials as of March 2024.
-
Which country conducted the highest number of Arthralgia clinical trials in March 2024?
China conducted the highest number of Arthralgia clinical trials as of March 2024.
-
Which sponsor type was the most prominent in the Arthralgia clinical trials in March 2024?
As of March 2024, company sponsor type conducted most of the Arthralgia clinical trials.
-
Which are the leading sponsors of Arthralgia clinical trials?
A few of the leading sponsors of Arthralgia clinical trials are Novartis AG, Johnson & Johnson, Reckitt Benckiser Group Plc, Grunenthal GmbH, and IBSA Institut Biochimique SA among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.